Simultaneous Integrated Boost Technique in Breast Cancer Radiotherapy
NCT ID: NCT04535895
Last Updated: 2022-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-04-16
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Simultaneous integrated boost (SIB) techniques have been shown to provide more conformal treatment plans than conventional sequential boost, in addition, SIB enables a reduction in the overall treatment time by 1 week compared to conventional boost techniques.
The proposed study is aimed at evaluating radiation-induced toxicity in patients treated with breast-conserving surgery in combination with radiotherapy using SIB technique.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Late Toxicity in Breast Cancer Patients Treated With Breast-conserving Surgical Procedures and Radiotherapy Using the Simultaneous Integrated Boost Technique
NCT02505906
Comparison of Acute Toxicity and Cost Between Whole Breast Irradiation With Sequential Boost and Simultaneous Integrated Boost After Breast Conserving Surgery.
NCT01973634
Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer
NCT02474641
Highly Accelerated Dose-Integrated Radiotherapy in 5 Fractions in Breast Cancer
NCT04098926
Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years
NCT03121248
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Simultaneous integrated boost arm
Simultaneous integrated boost
Adjuvant breast cancer irradiation including simultaneous integrated boost
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Simultaneous integrated boost
Adjuvant breast cancer irradiation including simultaneous integrated boost
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Breast conserving surgery
* Complete tumor resection
* Treatment with adjuvant radiotherapy of the breast
* Indication for boost Irradiation
* Given informed consent
Exclusion Criteria
* Mastectomy
* Distant metastases at diagnosis
* Unable to give informed consent
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tanja Langsenlehner, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Graz, Dept. of Therapeutic Radiology and Oncology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Graz
Graz, , Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hurkmans CW, Dijckmans I, Reijnen M, van der Leer J, van Vliet-Vroegindeweij C, van der Sangen M. Adaptive radiation therapy for breast IMRT-simultaneously integrated boost: three-year clinical experience. Radiother Oncol. 2012 May;103(2):183-7. doi: 10.1016/j.radonc.2011.12.014. Epub 2012 Jan 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1094/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.